Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Clinical trial NCT01705184 · COMPLETED

Trial details

NCT number: NCT01705184
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic Nonsquamous Nonsmall Cell Neoplasm of Lung

Start date: 2012-12-01
Primary completion: 2016-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.